A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients

Status:
Completed

Trial end date:
2005-05-01

Target enrollment:

Participant gender:

The purpose of this study is to compare the efficacy and safety of ziprasidone and risperidone for the treatment of schizophrenia in Chinese patients

Phase 3

Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Risperidone
Ziprasidone